Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Virology. 2011 Jul 19;417(2):379–384. doi: 10.1016/j.virol.2011.06.021

Fig 3. S-OIV-3B2 inhibits lung virus replication in challenged mice.

Fig 3

Mice (n=3/group) were treated with 12.5 mg/kg of S-OIV-3B2 at 24 h before (bc) or after challenge (ac) with 10 MLD50 of ma-Ca/04. The mock-treated mice received 14 mg/kg doses of control IgG mAb (2B9) at 24 h before challenge. At day 3 post-challenge, lungs were homogenized and viruses in homogenates were titrated in MDCK cells. BLD, below the limit detection.